We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$150B
Turnover
14.09%
1-Year Est. Return
40.08%
This Fund
S&P 500
This Quarter
Est. Return
+12.24%
1 Year Est. Return
+40.08%
3 Year Est. Return
+113.08%
5 Year Est. Return
+141.06%
10 Year Est. Return
+565.4%
AUM
$130B
AUM Growth
+$10.6B
(+8.8%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
21.27%
Holding
2,138
New
167
Increased
1,007
Reduced
798
Closed
89
Avg Time Held Equity + Options
5.5
years
Top 10 Avg Time Held Equity + Options
5.6
years
Top 20 Avg Time Held Equity + Options
4.4
years
Avg Time Held Equity only
5.5
years
Top 10 Avg Time Held Equity only
5.6
years
Top 20 Avg Time Held Equity only
4.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$338M |
| 2 |
Meta Platforms (Facebook)
META
|
+$297M |
| 3 |
Boeing
BA
|
+$208M |
| 4 |
UnitedHealth
UNH
|
+$183M |
| 5 |
Linde
LIN
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kroger
KR
|
+$306M |
| 2 |
Accenture
ACN
|
+$268M |
| 3 |
Goldman Sachs
GS
|
+$191M |
| 4 |
Palantir
PLTR
|
+$169M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.98% |
| 2 | Financials | 14.56% |
| 3 | Industrials | 11.84% |
| 4 | Consumer Discretionary | 9.48% |
| 5 | Healthcare | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
951
Emera Inc
EMA
$14.5B
| $5.34M | ﹤0.01% |
+116,857
| New | +$5.25M |
2025 Q2
0 quarters
|
|
952
Nextpower Inc. Common Stock
NXT
$12.7B
| $5.29M | ﹤0.01% |
97,241
-274,841
| -74% | -$13.8M |
2023 Q4
6 quarters
|
|
953
CarMax
KMX
$7.47B
| $5.29M | ﹤0.01% |
78,658
-15
| -0% | -$1.01K |
2013 Q2
48 quarters
|
|
954
AutoNation
AN
$5.28B
| $5.26M | ﹤0.01% |
26,485
+3,458
| +15% | +$624K |
2013 Q2
48 quarters
|
|
955
Microchip Technology
MCHP
$40.3B
| $5.21M | ﹤0.01% |
74,023
+24,979
| +51% | +$1.37M |
2020 Q4
18 quarters
|
|
956
Protagonist Therapeutics
PTGX
$8.84B
| $5.17M | ﹤0.01% |
+93,582
| New | +$4.49M |
2025 Q2
0 quarters
|
|
957
Fidelity National Information Services
FIS
$18.6B
| $5.16M | ﹤0.01% |
63,409
+4,447
| +8% | +$346K |
2013 Q2
48 quarters
|
|
958
Sterling Infrastructure
STRL
$13.7B
| $5.08M | ﹤0.01% |
+21,999
| New | +$3.84M |
2025 Q2
0 quarters
|
|
959
US Bancorp
USB
$89.4B
| $5.07M | ﹤0.01% |
112,120
-1,288
| -1% | -$54.2K |
2013 Q2
48 quarters
|
|
960
Four Corners Property Trust
FCPT
$2.39B
| $5.03M | ﹤0.01% |
187,089
+6,146
| +3% | +$169K |
2015 Q4
38 quarters
|
|
961
Tenet Healthcare
THC
$22.2B
| $5M | ﹤0.01% |
28,396
+7,532
| +36% | +$1.13M |
2023 Q2
8 quarters
|
|
962
Privia Health
PRVA
$2.89B
| $4.99M | ﹤0.01% |
216,903
+26,651
| +14% | +$617K |
2025 Q1
1 quarter
|
|
963
Ashland
ASH
$3.28B
| $4.95M | ﹤0.01% |
98,504
-16,216
| -14% | -$824K |
2013 Q2
48 quarters
|
|
964
Kratos Defense & Security Solutions
KTOS
$7.65B
| $4.94M | ﹤0.01% |
106,336
+9,716
| +10% | +$352K |
2020 Q3
19 quarters
|
|
965
Brown & Brown
BRO
$22.7B
| $4.93M | ﹤0.01% |
44,485
-245,219
| -85% | -$27.6M |
2021 Q1
17 quarters
|
|
966
Raymond James Financial
RJF
$30.3B
| $4.91M | ﹤0.01% |
32,052
+5,827
| +22% | +$834K |
2021 Q1
17 quarters
|
|
967
Toll Brothers
TOL
$12.3B
| $4.91M | ﹤0.01% |
42,983
+10,896
| +34% | +$1.13M |
2020 Q2
20 quarters
|
|
968
Morgan Stanley Direct Lending Fund
MSDL
$1.12B
| $4.9M | ﹤0.01% |
261,767
+20,212
| +8% | +$391K |
2024 Q4
2 quarters
|
|
969
Labcorp
LH
$26.4B
| $4.88M | ﹤0.01% |
18,604
+1,125
| +6% | +$274K |
2013 Q2
48 quarters
|
|
970
UMH Properties
UMH
$1.3B
| $4.76M | ﹤0.01% |
283,771
-8,987
| -3% | -$154K |
2014 Q4
42 quarters
|
|
971
Corcept Therapeutics
CORT
$12.3B
| $4.76M | ﹤0.01% |
64,879
+8,959
| +16% | +$650K |
2024 Q3
3 quarters
|
|
972
New York Times
NYT
$11.1B
| $4.74M | ﹤0.01% |
84,619
+15,452
| +22% | +$819K |
2023 Q2
8 quarters
|
|
973
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.73B
| $4.72M | ﹤0.01% |
175,897
+599
| +0.3% | +$15.5K |
2013 Q2
48 quarters
|
|
974
Vericel Corp
VCEL
$2.1B
| $4.72M | ﹤0.01% |
110,966
+363
| +0.3% | +$15.1K |
2023 Q4
6 quarters
|
|
975
iShares MSCI Taiwan ETF
EWT
$11.9B
| $4.71M | ﹤0.01% |
81,971
-6,841
| -8% | -$350K |
2013 Q2
48 quarters
|
|
Similar funds
Neuberger Berman Group's Q2 2025 Portfolio in Review
As of Q2 2025, Neuberger Berman Group held 2,138 positions worth $130B, up 8.8% from $119B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Neuberger Berman Group's Q2 2025 filing shows 167 new, 1,007 increased, 798 reduced and 89 closed positions. Its largest new stake was Caris Life Sciences: 6,239,520 shares worth $167M. The largest sale was Kroger, an estimated $306M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Neuberger Berman Group's largest Q2 2025 buy was Caris Life Sciences: 6,239,520 shares worth $167M.
- Neuberger Berman Group added most to Home Depot in Q2 2025, an estimated $338M increase.
- Neuberger Berman Group's biggest Q2 2025 reduction was Kroger, cutting an estimated $306M.
- Neuberger Berman Group fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2025, selling an estimated $73.6M.
- Neuberger Berman Group's ten largest holdings make up 21% of its $130B portfolio in Q2 2025.
- Neuberger Berman Group opened 167 new positions and closed 89 in Q2 2025.
- Neuberger Berman Group's portfolio value rose 8.8% quarter-over-quarter to $130B.
Based on Neuberger Berman Group's 13F filing for Q2 2025, filed 13 Aug 2025.